Latest News view all news

12/27/2022

Please join LIBTAYO for a live presentation on the latest data for LIBTAYO

12/15/2022

Mirati announces New Therapy Targeting KRAS G12C Mutation for Metastatic NSCLC.

11/21/2022

LIBTAYO® (cemiplimab-rwlc) is now FDA-approved

10/03/2022

The Eisai Assistance Program

Visit eisaireimbursement.com or call 1-866-61-EISAI (1-866-613-4724)

Upcoming Events view all events

 March 2023 
SMTWTFS
   1234
567891011
12131415161718
19202122232425
262728293031 
Wed
7
2023
June 7-8, 2023

NJSOM Summer Conference

view event details
Thu
2
2023
November 2, 2023
8:00AM - 3:00PM

NJSOM Winter Conference

view event details

Corporate Members view all sponsors